These stocks are making BIG moves 📈

These stocks are making big moves in today's premarket....                                                                                                                                                                                                                                                                                                                                                                                                                 November 27, 2023 | [Read Online]( [Chris Dinello]( November 27, 2023 Sponsored by Good Afternoon! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Monday! It’s November 27th. I hope you had a great weekend. 🔥  Our blowout Black Friday deal on Elite Growth Stocks is still live! We got a great response so we’re extending it one last time for Cyber Monday. [Claim your discount]( by midnight ET tonight to or you could miss out. Now, let's get ready to trade! Brought to You By Harness The Economist's approach to business writing How do you write persuasively for business? Study the psychology, craft and purpose of writing with experts from The Economist. The six-week [Professional Communication: Business Writing and Storytelling]( online short course from The Economist is designed to help business professionals attract and address broad audiences across various written formats. On completion of this course, you’ll walk away with: - Practical writing, editing and data-visualisation skills for creating clear and compelling business communications. - A writer’s toolkit based on The Economist’s editorial approach, helping you to navigate questions of structure, word choice and style. - The ability to source, structure and convey information in a way that is accurate, engaging and ethical. [LEARN MORE]( Markets 📈 Stocks closed Friday’s half-day session with mixed results. The Dow added 0.3%, while the S&P 500 added less than 0.1%. The Nasdaq ended the day down 0.1%, and the small-cap Russell 2K outperformed with a 0.6% advance. Futures are down in early trading. S&P 500 contracts are showing a 0.1% decline. Premarket Highlights 🔎 🕊 None It’s been a quiet start to the trading day. Everyone is still waking up from their holiday slumber. I expect a rather tame trading session today. What to Watch Today 🔍 New Home Sales Today’s calendar doesn’t have any major events that catch my eye, but the New Home Sales report could be worth a peek. High mortgage rates and plummeting inventories have strangled the home buying market, but prices remain elevated in many areas. This report could provide some valuable insights in an otherwise uneventful trading day. Featured Earnings 💲 - UP Fintech Holding Limited [TIGR] ... AM - Cerence [CRNC] ... AM - Anavex Life Sciences [AVXL] ... AM - Smart Share Global Limited [EM] ... AM - Zscaler [ZS] ... PM - Cango [CANG] ... PM Economy 🏗 - New home sales [Oct] ... 10:00a Running Hot 🔥 Gainers - Mobiquity Tech [MOBQ] >> +32.6% - Ambow Education [AMBO] >> +20.2% - Capitvision [CAPT] >> +11.5% Decliners - Conifer Holdings [CNFR] >> (31.0%) - BioNexus Gene Lab [BGLC] >> (24.3%) - Impel Neuropharma [IMPL] >> (27.0%) Crown Castle [CCI] - Last Close: $103.58 Activist investors have their sights on Crown Castle. This morning, a WSJ report claimes Elliott Management had amassed a $2 billion stake in CCI in an effort to force change at the wireless tower operator. Elliott made a similar attempt in the past with Crown Castle, but the effort produced limited success. Now, the activist hedge fund wants to engage with Crown Castle and explore strategies for improving the performance of its shares. In the past, Elliott has criticized Crown Castle’s fiber strategy as “undisciplined” and called on management to focus on higher-return opportunities. CCI is leading the S&P 500 with a 4.9% gain on news of the activist renewed investor’s interest in the company. My Take: CCI has been trending higher since mid-October, but it ran into stiff resistance at $105 per share. Today’s rally is currently on pace to break through this resistance point. Apollomics [APLM] - Last Close: $0.9972 Apollomics is extending its hot streak. The tiny biotech firm has been on a tear since last week, when HC Wainwright analysts maintained a $17 price target and reiterated their “buy” rating. The bullish analyst note came shortly after Apollomics partner in China, Avistone Biotechnology, got conditional approval for commercialization of vebreltinib. Since then, shares have been on a tear. As of Friday’s close, APLM was up 74.9% over the past 30 days, and it’s running hot again today. APLM is one of this morning’s top performers with a 30.3% gain on elevated trading volume. My Take: APLM’s whopping 29.3% short percentage as of Oct. 31st could be fueling the stock’s dramatic rise over the past week. Just be careful you make your exit before the squeeze runs out of steam. RedHill Biopharma [RDHL] - Last Close: $0.3155 RedHill Bio is rallying on a regulatory ruling. This morning, the company said the FDA granted it a 5-year U.S. market exclusivity for Talicia® under a special approval for antibiotics. The FDA’s ruling will extend RedHill intellectual property protection on on the drug until 2034. Talicia is a first-line antibiotic for U.S. gastroenterologists treating H. pylori - a bacterial infection that affects approximately 35% of the U.S. adult population. RDHL is a top performer today with a 153.2% gain on elevated volume. My Take: This is big news for RDHL, but the rally seems overdone. I success the stock’s 35.0% short ratio could be playing a hand in this meteoric rally. Near Intelligence [NIR] - Last Close: $0.1482 Near Intelligence is rebounding after a recent slide. Shares of the stock began selling off on Tuesday of last week, when the company announced the termination of its CEO, Rahul Agarwal, effective immediately. Near Intelligence also took a hit when it missed its 10-Q quarterly financials filing deadline shortly before announcing the firing its CEO. Altogther, NIR is down 21.9% over the past 10 days, but the drawdown may have been overdone because shares are suddenly rebounding today. NIR is one of this morning’s top stocks with a 30.8% gain on elevated trading volume. My Take: NIR doesn’t have an elevated short percentage, although its short rate may have risen since the last data point on Oct. 31st. Judging from its recent price action, the company’s recent sell-off may have been somewhat overdone. That's it for today! Thanks for reading, and good luck out there! Best Regards, — Chris D. Elite Trade Club Text ELITE to 47121 or [click here]( to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2023 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America